Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson… - The Lancet …, 2020 - thelancet.com
Background Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson, C Le Berre… - The Lancet …, 2020 - Elsevier
Background Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson… - The Lancet …, 2020 - thelancet.com
Background Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

[PDF][PDF] Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large …

A Chevance, P Ravaud, A Tomlinson, C Le Berre… - Lancet, 2020 - eiko-fried.com
Background Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson, C Le Berre… - Lancet psychiatry, 2020 - safetylit.org
BACKGROUND: Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson… - The lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

[引用][C] Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large …

A Chevance, P Ravaud, A Tomlinson… - 2020 - scholarlypublications …
Identifying outcomes for depression that matter to patients, informal caregivers, and health-care
professionals: qualitative content analysis of a large international online survey | Scholarly …

" Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: Qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson, C Le Berre… - 2020 - psycnet.apa.org
Reports an error in" Identifying outcomes for depression that matter to patients, informal
caregivers, and health-care professionals: Qualitative content analysis of a large …

Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson… - The Lancet …, 2020 - research.imc.ac.at
Background: Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …

Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international …

A Chevance, P Ravaud, A Tomlinson, C Le Berre… - The Lancet …, 2020 - hal.science
Background Many clinical trials have assessed treatments for depressive disorders and
bipolar depression. However, whether, and which, assessed outcome domains really matter …